Valo Health
Data as of .
Company facts
-
Founded
2019
-
Headquarters
United States (Boston, MA)
-
Total funding
more than $450M
Latest funding round
- Round
- Series B
- Date
- Mar 2021
- Amount
- $300M
- Lead investor
- Koch Disruptive Technologies ($110M close)
Drug discovery partners
2 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
Merck KGaA Pharma
Parkinson's collaboration,
More than $3B
-
Novo Nordisk Pharma
Expanded collaboration,
$190M upfront ($4.6B total potential)
Recent news
-
Appoints Chris Anagnostopoulos as Chief Causal AI Officer
-
Appoints Rita Kale as Chief Financial Officer
-
Collaboration with Merck KGaA in Parkinson's disease (official)
-
Expanded collaboration with Novo Nordisk ($190M upfront ($4.6B total potential))
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.